New treatment breakthrough: Pyrotinib combo demonstrates remarkable efficacy for HER2
The safety and efficacy of treating human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer with pyrotinib.
More... |
All times are GMT -7. The time now is 07:57 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021